Studies on the chemistry, antitumor activity, and pharmacology of ethyl di-(2,2-dimethyl)ethylenamido phosphate (AB-163).
D000477:Alkylating Agents / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D001388:Aziridines; D001389:Azirines / Q000008:administration & dosage / Q000633:toxicity; D001835:Body Weight; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002490:Central Nervous System / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D004285:Dogs; D005260:Female; D005622:Friend murine leukemia virus; D006410:Hematopoiesis / Q000187:drug effects; D006868:Hydrolysis; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000188:drug therapy; D000637:Transaminases / Q000097:blood; D014184:Transplantation, Homologous
D000477:Alkylating Agents; D001388:Aziridines; D001389:Azirines; C001181:AB 163; D007770:L-Lactate Dehydrogenase; D000637:Transaminases